Porphyromonas gingivalis recombinant proteins and truncations
CA 2750984 A1 · Owner: Csl Limited · Inventors: Ross, Bruce Carter; Czajkowski, Larissa; Barr, Ian George
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to soluble P. gingivalis polypeptides derived from , PG32 and PG33 and to polynucleotides encoding these polypeptides. The P. gingivalis polypeptides and nucleotides can be used in compositions for use in raising an immune response in a subject against P. gingivalis and treating or preventing or reducing the severity of the condition known as periodontitis or in , other conditions related to infection with P. gingivalis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.